Automated Method for Detecting Increases in Frequency of Spontaneous Adverse Event Reports over Time
Overview
Public Health
Affiliations
A statistical methodology--focused on temporal change detection--was developed to highlight excursions from baseline spontaneous adverse event (AE) reporting. We used regression (both smooth trend and seasonal components) to model the time course of a drug's reports containing an AE, and then compared the sum of counts in the past 2 months with the fitted trend. The signaling threshold was tuned, using retrospective analysis, to yield acceptable sensitivity and specificity. The method may enhance pharmacovigilance by providing effective automated alerting of reporting aberrations when databases are small, when drugs have established safety profiles, and/or when product quality issues are of concern.
Wilde J, Springs S, Wolfrum J, Levi R Drug Saf. 2023; 46(11):1117-1131.
PMID: 37773567 DOI: 10.1007/s40264-023-01349-6.
Pinheiro L, Candore G, Zaccaria C, Slattery J, Arlett P Pharmacoepidemiol Drug Saf. 2017; 27(1):38-45.
PMID: 29143393 PMC: 5765515. DOI: 10.1002/pds.4344.
Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites.
Juhlin K, Karimi G, Ander M, Camilli S, Dheda M, Har T Drug Saf. 2015; 38(4):373-82.
PMID: 25687792 PMC: 4544545. DOI: 10.1007/s40264-015-0271-2.